Bristol Myers Squibb completes $14 billion acquisition of Karuna Therapeutics from PureTech
Yesterday (March 18) PureTech Health plc announced the completion of the acquisition of its founded entity, Karuna Therapeutics, Inc., by Bristol Myers Squibb for a staggering $14 billion.